Qdenga (TAK-003): India Approves Its First Dengue Vaccine
Why in the news
The country got its first vaccine against dengue in July 2026, after the drug regulator cleared a candidate for use.
Key facts
- Vaccine: QDENGA (TAK-003).
- Cleared by: Drug Controller General of India (DCGI).
- Protection: all four dengue virus serotypes.
| Feature | Detail |
|---|---|
| Eligible age | 4 to 60 years |
| Schedule | Two doses |
| Serotypes covered | All four |
Significance
- It is the first dengue vaccine to receive approval in India.
Exam angle
- Vaccine name and code: QDENGA, TAK-003.
- Approving authority: DCGI.
- Age band: 4 to 60 years.